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Abstract Evidence suggests that glucosamine inhibits distal
components regulating insulin-stimulated GLUT4 translocation
to the plasma membrane. Here we assessed whether key mem-
brane docking and fusion events were targeted. Consistent with
a plasma membrane-localized e¡ect, 3T3-L1 adipocytes exposed
to glucosamine displayed an increase in cell-surface O-linked
glycosylation and a simultaneously impaired mobilization of
GLUT4 by insulin. Analysis of syntaxin 4 and SNAP23, plasma
membrane-localized target receptor proteins (t-SNAREs) for
the GLUT4 vesicle, showed that they were not cell-surface tar-
gets of O-linked glycosylation. However, the syntaxin 4 binding
protein, Munc18c, was targeted by O-linked glycosylation. This
occurred concomitantly with a block in insulin-stimulated asso-
ciation of syntaxin 4 with its cognate GLUT4 vesicle receptor
protein (v-SNARE), VAMP2. In conclusion, our data suggest
that the mechanism by which glucosamine inhibits insulin-stimu-
lated GLUT4 translocation involves modi¢cation of Munc18c.
5 2002 Federation of European Biochemical Societies. Pub-
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1. Introduction
Insulin normalizes elevated plasma glucose levels mainly by
increasing glucose uptake into fat and muscle cells, via stim-
ulating the translocation of the insulin-responsive glucose
transporter GLUT4 from intracellular sites to the plasma
membrane. GLUT4 resides in vesicles that continuously cycle
from intracellular stores to the plasma membrane. Insulin in-
creases glucose transport by greatly increasing the rate of
GLUT4-containing vesicle exocytosis and slightly decreasing
the rate of internalization [1]. This insulin-stimulated process
requires phosphatidylinositol 3-kinase (PI3K) as well as a
proposed PI3K-independent pathway leading to activation
of the small GTPase TC10 [2]. Disconnect in the PI3K signal
linking the insulin receptor (IR) to the GLUT4 protein has
been described, and is speculated to be a molecular and phys-
iological basis of insulin resistance in obesity and type 2 dia-
betes.
Insulin resistance, the inability of cells or tissues to respond
to physiological levels of insulin, results in profound dysregu-
lation of glucose transport. Evidence indicates that the glu-
cosamine biosynthetic pathway, a quantitatively small path-
way of glucose utilization, may contribute to the insulin-
resistant state [3^6]. The ¢rst and rate-limiting enzyme of
the hexosamine biosynthesis pathway is glutamine:fructose-
6-phosphate amidotransferase (GFAT), which catalyzes the
conversion of fructose-6-phosphate to glucosamine-6-phos-
phate. This pathway ultimately produces UDP^N-acetylglu-
cosamine (UDP^GlcNAc) and UDP^N-acetylgalatosamine,
which serve as obligatory precursors for the synthesis of gly-
cosyl side chains of proteins and lipids. Experimentally, work
from this and other laboratories suggest that defects in the
PI3K and/or the TC10 signaling routes engaged by insulin to
mobilize GLUT4 do not readily account for glucosamine-in-
duced insulin resistance [7^9]. In agreement with a distally
targeted glucosamine-induced defect, the insulin mimetic ac-
tion of hyperosmolarity, which is independent of early com-
ponents of insulin action, is also blocked in cells exposed to
glucosamine [7]. Although mobilization of GLUT4 by hyper-
osmolarity does not entirely utilize the same signal transduc-
tion pathways of insulin action [10,11], stimulation by hyper-
osmolarity appears to require some of the same distally
targeted proteins of insulin action that regulate GLUT4
vesicle and plasma membrane fusion [11,12].
The mechanism of membrane fusion entails the pairing of
protein complexes in the vesicle compartment (v-SNAREs, for
vesicle SNAP receptors) with cognate receptor complexes at
the target membrane (t-SNAREs, for target membrane SNAP
receptors). Several v- and t-SNARE proteins have been iden-
ti¢ed that speci¢cally participate in the insulin-regulated dock-
ing and fusion of GLUT4 vesicles with the plasma membrane
[1,13^15]. Syntaxin 4 appears to function as the required plas-
ma membrane t-SNARE, whereas VAMP2 is the predomi-
nant v-SNARE for insulin-stimulated GLUT4 vesicle docking
and fusion [16^20]. Several accessory proteins such as
Munc18c have been shown to play important functional roles
in regulation of insulin-stimulated t- and v-SNARE interac-
tions [12,21^24].
Clear functional consequences of abnormal glycosylation
events are only beginning to be elucidated but most modi¢-
cations a¡ect a protein^protein association or a¡ect protein
activity directly [25]. Recently, glycosylation has been impli-
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cated to have a functional role in SNARE protein interactions
[26]. Given that both insulin- and hyperosmolarity-stimulated
GLUT4 translocations are negatively a¡ected by glucosamine
and that they apparently share proteins involved in membrane
docking and fusion events, the purpose of the present study
was to determine whether increases in the hexosamine biosyn-
thesis pathway impair SNARE protein interaction involved in
GLUT4 translocation. Here we demonstrate that Munc18c
isolated from cells exposed to glucosamine is O-linked glyco-
sylated. Furthermore, the insulin-stimulated association of
VAMP2 and syntaxin 4 is prevented by glucosamine treat-
ment. The following sections describe these ¢ndings in detail.
2. Materials and methods
2.1. Cell culture
Murine 3T3-L1 preadipocytes were obtained from the American
Type Tissue Culture repository and were cultured in Dulbecco’s modi-
¢ed Eagle’s medium (DMEM) containing 25 mM glucose and 10%
calf serum at 37‡C in an 8% CO2 atmosphere. Con£uent cultures were
induced to di¡erentiate into adipocytes as previously described [27].
All studies were performed on adipocytes, which were between 8 and
12 days old following di¡erentiation. Prior to all experimental treat-
ments, the di¡erentiated adipocytes were serum starved in DMEM
containing 5.5 mM glucose for 2 h at 37‡C.
2.2. Glucosamine induction of insulin resistance
As we have previously reported [7], we utilized a glucosamine-in-
duced model described by Ross et al. [8] that induces insulin resistance
without a¡ecting neither the cellular ATP levels nor the early insulin-
regulated phosphorylation of substrates. Brie£y, prior to induction of
insulin resistance adipocytes were treated with DMEM/5.5 mM glu-
cose media containing 10% fetal bovine serum (FBS) for two days.
Cells were then treated with DMEM containing 10% FBS and 2 mM
glucosamine and lacking glucose, glutamine, and insulin for 12^14 h.
The culture media contained 1 mM pyruvate as an additional energy
source. Also, 2 mM L-glucose was added to adjust the osmolarity of
sugars in control groups.
2.3. Transient transfection
Di¡erentiated adipocytes were electroporated (0.16 kV and 960 WF)
as previously described [21]. As indicated in the ¢gure legends, trans-
fection experiments were performed with 50 Wg of enhanced green
£uorescent protein (EGFP)-tagged plasmid DNA for analysis of
EGFP £uorescence. Following electroporation, the adipocytes were
re-plated on glass coverslips and allowed to recover for 16^18 h before
use.
2.4. Plasma membrane sheet assay
Preparation of plasma membrane sheets from the adipocytes was
performed essentially by the method of Robinson et al. [28] with
minor modi¢cations as previously described [27]. Following the iso-
lation of plasma membrane sheets, these puri¢ed membranes were
used for indirect immuno£uorescence. The plasma membrane sheets
were ¢xed for 20 min at 25‡C in a solution containing 2% parafor-
maldehyde, 70 mM KCl, 30 mM HEPES, pH 7.5, 5 mM MgCl2, and
3 mM EGTA as previously described [27]. The membrane sheets were
then blocked in 5% donkey serum for 60 min at 25‡C, incubated for
60 min at 25‡C with a 1:100 dilution of RL-2, a monoclonal mouse
antibody against O-linked N-acetylglucosylation (A⁄nity Bioreagents
Inc.) in 5% donkey serum followed by incubation with a 1:50 dilution
of rhodamine red-X-conjugated donkey anti-mouse immunoglobulin
G (Jackson Immunoresearch Inc.) for 60 min at 25‡C.
2.5. Preparation of total cell extracts and immunoprecipitation
Total cell extracts were prepared from 100-mm plates of 3T3-L1
adipocytes following the appropriate treatment. Cells from each plate
were washed two times with ice-cold phosphate-bu¡ered saline and
scraped into 1 ml of lysis bu¡er (25 mM Tris, pH 7.4, 50 mM NaF, 10
mM Na3P2O7, 137 mM NaCl, 10% glycerol and 1% NP40) containing
1.0 mM phenylmethylsulfonyl £uoride, 2 mM Na3VO4, 5 Wg ml31
aprotinin, 2.5 Wg ml31 leupeptin, and 1 Wg ml31 pepstatin A by ro-
tation for 15 min at 4‡C. Insoluble material was separated from the
soluble extract by microcentrifugation for 15 min at 4‡C. Protein
concentration was determined, and samples were either subjected di-
rectly to sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE, as described in Section 2.7) or immunoprecipitated
for syntaxin 4, Munc18c or VAMP2. Brie£y, 3^5 mg of cellular pro-
tein were immunoprecipitated with 4.5 Wg of rabbit anti-syntaxin
4 polyclonal antibody (Chemicon International Inc.) and 2.0 Wg of
rabbit anti-Munc18c a⁄nity-puri¢ed polyclonal antibody (generously
provided by Dr. Je¡rey Pessin, University of Iowa) for 2 h at 4‡C.
Immune complexes were recovered by the addition of protein A-Seph-
arose (Amersham Pharmacia Biotech) and subjected to SDS^PAGE
(as described in Section 2.7).
2.6. Subcellular fractionation
Adipocyte subcellular membrane fractions were obtained using the
di¡erential centrifugation method previously described [21] with slight
modi¢cation. Brie£y, control and insulin-stimulated 3T3-L1 adipo-
cytes were washed and resuspended in HES bu¡er (20 mM HEPES,
pH 7.4, 1 mM EDTA, and 255 mM sucrose containing 1 mM phen-
ylmethylsulfonyl £uoride, 10 Wg ml31 pepstatin, 10 Wg ml31 aprotinin,
and 5 Wg ml31 leupeptin). Cell lysates were prepared by shearing the
cells through a 22-gauge needle 10 times. Lysates were then centri-
fuged at 19 000Ug for 20 min at 4‡C. The low speed pellet was
obtained by centrifugation of the resulting supernatant at 41 000Ug
for 20 min at 4‡C. Supernatant was removed and centrifuged at
180 000Ug for 75 min at 4‡C to generate the high speed pellet and
cytosol (supernatant) fractions. The crude plasma membrane pellet
was obtained by resuspending the pellet from the initial 19 000Ug
centrifugation in HES bu¡er followed by layering onto a 1.12 M
Fig. 1. Glucosamine exposure results in O-linked glycosylation of
cell-surface proteins concomitant with a blockade in insulin-stimu-
lated GLUT4^EGFP translocation. 3T3-L1 adipocytes were electro-
porated with 50 Wg of the GLUT4^EGFP cDNA (panels 1^4). Fol-
lowing a 24 h recovery, the cells were incubated in the absence
(3GlcN, panels 1 and 2) or presence (+GlcN, panels 3 and 4) of
2 mM glucosamine for 12 h as described in Section 2. Cells were
subsequently left either untreated (control, C, panels 1 and 3) or
treated with 100 nM insulin (insulin, panels 2 and 5) for 15 min.
Cells were then subjected to immuno£uorescence microscopy with
an antibody that recognizes polypeptides containing O-linked N-ace-
tylglucosamine residues (RL2). Nuclear (n) and plasma (arrow)
membranes are denoted. Representative observations from three in-
dependent experiments are shown.
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sucrose cushion for centrifugation at 100 000Ug for 60 min. The
plasma membrane layer was removed from the sucrose cushion and
centrifuged at 40 000Ug for 20 min. All pelleted fractions were resus-
pended in a detergent-containing lysis bu¡er and assayed for soluble
protein content.
2.7. Electrophoresis and immunoblotting
Whole cell lysates, immunoprecipitated proteins, and subcellular
fractions were subjected to electrophoresis on a 12% SDS^PAGE,
transferred to polyvinylidene di£uoride membranes (Millipore), and
immunoblotted with antibodies indicated in the individual ¢gure
legends. All immunoblots were subjected to enhanced chemilumines-
cence detection (Amersham Pharmacia Biotech).
2.8. Statistical analysis
All values are presented as meansTS.E., and signi¢cant di¡erences
between means were evaluated by paired Student’s t-test. For testing
multiple pairs, analysis of variance was used to determine di¡erences
among groups. Where a signi¢cant di¡erence was indicated, the New-
man^Keuls Test was used to determine signi¢cant di¡erences between
groups. P6 0.05 was considered to be statistically signi¢cant.
3. Results
3.1. E¡ect of glucosamine on the cellular distribution of
O-linked glycosylated proteins and GLUT4 translocation
GLUT4^EGFP-expressing cells pretreated with 2 mM glu-
cosamine for 12 h displayed a marked increase in O-linked
glycosylation at the cell surface compared to cells pretreated
in the absence of glucosamine (Fig. 1, compare panels 1^4).
Consistent with other reports, nuclear membrane labeling was
detected in all cells [29^31]. In the absence of glucosamine
exposure, insulin treatment for 15 min stimulated a character-
istic increase in GLUT4^EGFP translocation (Fig. 1, compare
panels 1 and 2). In contrast, the ability of insulin to mobilize
GLUT4^EGFP to the cell surface was blocked in glucosam-
ine-exposed cells (Fig. 1, panel 4). Consistent with the in-
creased cell-surface immunoreactivity, highly puri¢ed plasma
membrane sheets prepared from cells pretreated with glucos-
amine displayed a marked increase in immuno£uorescence
detection of O-linked glycosylation compared to sheets from
untreated cells (Fig. 2A, compare panels 1 and 2). In addition,
immunoblot analyses of plasma membrane fractions show
that the ability of insulin to mobilize GLUT4 to the plasma
membrane is blocked following glucosamine exposure (Fig.
2B). Collectively, these data clearly show that the glucosam-
ine-induced blockade in GLUT4 translocation occurs con-
comitant with O-linked glycosylation of plasma membrane-
localized proteins.
3.2. E¡ect of glucosamine on the cellular distribution and
O-linked glycosylation state of SNARE and
SNARE-associated proteins
We next assessed whether key SNARE and SNARE-asso-
ciated proteins involved in GLUT4 translocation were af-
fected by glucosamine treatment. As expected, insulin stimu-
lation for 15 min markedly increased plasma membrane-
associated VAMP2 (Fig. 3A, compare lanes 1 and 2). Also
the basal-state levels of syntaxin 4 and its binding protein,
Munc18c, in the plasma membrane were increased following
insulin stimulation (Fig. 3A, compare lanes 1 and 2). In cells
treated with glucosamine, neither the syntaxin 4, Munc18c,
nor VAMP2 basal levels were a¡ected. However, the insu-
lin-stimulated plasma membrane contents of these SNARE
proteins were markedly decreased by glucosamine exposure
(Fig. 3A, lanes 3 and 4). Densitometry analysis of three inde-
pendent experiments clearly shows that glucosamine caused
defective insulin-stimulated redistribution of these key
GLUT4 e¡ector proteins (Fig. 3B^D). Given that cells ex-
Fig. 2. O-linked glycosylated proteins are detected in highly puri¢ed plasma membrane sheets concomitant with a decrease in the insulin-stimu-
lated plasma membrane level of GLUT4. 3T3-L1 adipocytes were incubated in the absence (3GlcN, panel 1 and lanes 1 and 2) or presence
(+GlcN, panel 2 and lanes 3 and 4) of 2 mM glucosamine for 12 h as described in Section 2. A: Plasma membrane sheets were prepared and
subjected to immuno£uorescence microscopy with the RL2 antibody. Representative observations from three independent experiments are
shown. B: Following glucosamine treatment, cells were left untreated (3insulin, lanes 1 and 3) or treated with 100 nM insulin (+insulin, lanes
2 and 4) for 15 min. Plasma membrane fractions prepared as described in Section 2 were resolved on a 12% SDS^polyacrylamide gel and sub-
jected to Western blotting with the GLUT4 antibody. This is a representative immunoblot from three independent experiments.
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posed to glucosamine displayed a robust cell-surface immuno-
£uorescence labeling of O-linked glycosylation (Figs. 1 and
2A), we next assessed whether syntaxin 4 and SNAP23 were
modi¢ed by O-linked glycosylation following glucosamine
treatment. Immunoblotting analysis of these immunoprecipi-
tated plasma membrane-localized t-SNARE proteins with an
antibody that recognizes O-linked glycoproteins (RL2) re-
vealed that neither syntaxin 4 (Fig. 4A, compare lanes 1
and 2) nor SNAP23 (data not shown) were O-linked glycosy-
lated. In contrast, O-linked glycosylation of Munc18c was
apparent in cells treated with glucosamine (Fig. 4B, compare
lanes 1 and 2). Immunoblotting of the same Western blots
with syntaxin 4 (Fig. 4A, lanes 3 and 4) and Munc18c anti-
bodies (Fig. 4B, lanes 3 and 4) indicated the presence of equal
amounts of syntaxin 4 and Munc18c, respectively. In agree-
ment with these ¢ndings, immunoblotting analysis of RL2
immunoprecipitated O-linked glycosylated proteins clearly
demonstrated that Munc18c, but not syntaxin 4 was O-linked
glycosylated in cells exposed to glucosamine (Fig. 5, compare
lanes 1 and 2). Parallel immunoblotting of non-immunopreci-
pitated whole cell lysates from the same cells were resolved on
the same gel to con¢rm the migration of Munc18c and syn-
taxin 4 (Fig. 5, lanes 3 and 4). In addition to these immuno-
precipitation studies, we immuno£uorescently labeled control
and glucosamine-exposed cells with RL2 and Munc18c anti-
bodies. Consistent with the biochemical data, this microscopic
approach demonstrated a robust glucosamine-induced co-lo-
calization of Munc18c and O-linked glycosylation (data not
shown).
3.3. E¡ect of glucosamine on insulin-stimulated VAMP2 and
syntaxin 4 association
Finally, we assessed whether the extent of insulin-stimulated
Fig. 3. Insulin-stimulated tra⁄cking of several SNARE proteins to the plasma membrane is decreased by glucosamine. Following an overnight
treatment without (3GlcN, lanes 1 and 2) or with (+GlcN, lanes 3 and 4) glucosamine, cells were either left untreated (3insulin, lanes 1 and
3,) or treated with 100 nM insulin (+insulin, lanes 2 and 4) for 15 min. Plasma membrane fractions were prepared, resolved on a 12% polyac-
rylamide gel and subjected to Western blotting with the Munc18c, syntaxin 4, or VAMP2 antibodies. Representative immunoblots (A) and den-
sitometric quantitation (meansTS.E.) from three experiments (B^D) are shown. (*P6 0.05 versus 3GlcN/3insulin; **P6 0.05 versus 3GlcN/
+insulin).
Fig. 4. Glucosamine induces O-linked glycosylation of Munc18c,
but not syntaxin 4. Cells were incubated in the absence (3GlcN,
lanes 1 and 3) or presence (+GlcN, lanes 2 and 4) of 2 mM glucos-
amine for 12 h. Whole cell detergent extracts were prepared, immu-
noprecipitated with (A) syntaxin 4 or (B) Munc18c antibodies, re-
volved on a 12% polyacrylamide gel and subjected to Western
blotting with RL2 antibody (lanes 1 and 2). These same membranes
were stripped and reprobed with (A) syntaxin 4 or (B) Munc18c
antibodies. These are representative immunoblots from three inde-
pendent experiments.
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association of VAMP2 with syntaxin 4 was diminished in glu-
cosamine-exposed cells (Fig. 6). Insulin stimulation resulted in
a characteristic increase in the amount of VAMP2 co-im-
munoprecipitated with anti-syntaxin 4 antibody (Fig. 6, com-
pare lanes 1 and 2). The ability of insulin to stimulate this
VAMP2^syntaxin 4 association was completely blocked in
cells exposed to glucosamine (Fig. 6, compare lanes 3 and
4). Densitometry analysis of three separate independent ex-
periments clearly shows that the insulin-stimulated association
of VAMP2 with syntaxin 4 was prevented by glucosamine
(Fig. 6B).
4. Discussion
The main ¢nding of this study is that Munc18c, a key
mediator of membrane fusion events facilitating insulin-stimu-
lated GLUT4 translocation, is modi¢ed by O-linked glyco-
sylation in the glucosamine-induced insulin-resistant state.
Consistent with impaired insulin-stimulated GLUT4 translo-
cation, the insulin-stimulated translocation of VAMP2 to the
plasma membrane and its subsequent association with syntax-
in 4 were blocked in cells exposed to glucosamine. Since pre-
vious work from this and other laboratories demonstrates that
intermediates of the PI3K signal and the newly described Cbl
signal of insulin action are not altered by glucosamine treat-
ment, the data from the present study suggest that the glucos-
amine-induced defect in the insulin signal occurs at the level
of SNARE protein function. While this study was in progress,
Nelson et al. [32] reported that glucosamine treatment of 3T3-
L1 adipocytes disrupted the ability of insulin to promote the
translocation of Munc18c to the plasma membrane. Impor-
tantly, the present studies extended upon this observation and
demonstrated that Munc18c is a target of O-linked glycosyl-
ation. Furthermore, we show that the Munc18c-mediated
event of VAMP2^syntaxin 4 association is blocked in the glu-
cosamine-induced insulin-resistant state. Thus, the present
study provides a potential mechanism by which glucosamine
prevents insulin-stimulated GLUT4 translocation.
Studies in both skeletal muscle and 3T3-L1 adipocytes pro-
vide evidence against the insulin receptor being a plasma
membrane target of glucosamine action [7,8,33^36] and our
recent work supports a role at the more distal GLUT4-con-
taining vesicle and plasma membrane docking and fusion step
[7]. Consistent with this, our immuno£uorescence data as de-
termined by immunolabeling the cell (Fig. 1) and highly pu-
ri¢ed plasma membrane sheets (Fig. 2A) with RL2 antibody
indicates that plasma membrane proteins are targets of O-
linked glycosylation in glucosamine-induced insulin-resistant
3T3-L1 adipocytes. With regards to the GLUT4-containing
vesicle membrane, immunoisolation studies have revealed
that the rate of labeled glucosamine incorporation was ap-
proximately 100-fold greater following glucosamine compared
with saline infusions [37]. More recent work has shown that
there is enhanced O-linked glycosylation of GLUT4 in insu-
lin-resistant GLUT1-overexpressing muscles [38]. Although
studies demonstrate that neuron-speci¢c synaptic vesicle-asso-
ciated phosphoproteins synapsin I and synapsin II contain
Fig. 5. O-linked glycosylation of Munc18c is detected in RL2 immu-
noprecipitates. Following an overnight treatment without (3GlcN,
lanes 1 and 3) or with (+GlcN, lanes 2 and 4) glucosamine whole
cell detergent extracts were prepared and immunoprecipitated with
RL2 antibody, resolved on a 12% polyacrylamide gel (lanes 1 and
2). Non-immunoprecipitated lysates was resolved on the same gel
(lanes 3 and 4). The membrane was then subjected to Western blot-
ting with either (A) syntaxin 4 or (B) Munc18c antibodies. These
are representative immunoblots from three independent experiments.
Fig. 6. Stimulation of VAMP2 and syntaxin 4 association by insulin
is abolished in cells exposed to glucosamine. Whole cell detergent
extracts were prepared from non- (3GlcN, lanes 1 and 2) or glucos-
amine-exposed (+GlcN, lanes 3 and 4) cells that were either left un-
treated (3insulin, lanes 1 and 3) or treated with 100 nM insulin
(+insulin, lanes 2 and 4) for 15 min. Extracts were immunoprecipi-
tated with syntaxin 4 antibody, resolved on a 12% polyacrylamide
gel, and subjected to Western blotting with either syntaxin 4 or
VAMP2 antibodies. Representative immunoblots (A) and densito-
metric quantitation (meansTS.E.) from three experiments (B) are
shown. (*P6 0.05 versus 3GlcN/3insulin).
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O-glycosidically bound GlcNAc [26,39], like syntaxin 4 and
SNAP23, we did not detect O-linked glycosylation of VAMP2
in the present work (data not shown). In contrast, O-linked
glycosylation was clearly detected in anti-Munc18c immuno-
precipitates prepared from cells treated with glucosamine.
Moreover, we isolated Munc18c from glucosamine treated
cells via immunoprecipitation with the RL2 antibody and ad-
ditionally observed co localization immuno£uorescently. Col-
lectively, these ¢ndings importantly show that a key accessory
protein of insulin-stimulated VAMP2^syntaxin 4 association
is O-linked glycosylated in cells exposed to glucosamine.
Munc proteins share homology with two vesicle-tra⁄cking
regulators Sec1 in Saccharomyces cerevisiae and unc-18 in
Caenorhabditis elegans. Munc18a is expressed only in neuro-
nal and neuroendocrine tissues [40]. Munc18b and c are ex-
pressed in adipocytes, but only the latter regulates GLUT4
tra⁄cking [21,23,41]. Overexpression of Munc18c inhibited
GLUT4 translocation in response to insulin [12,21,24]. This
inhibitory e¡ect was removed by co-expression of syntaxin 4
[23]. In cells that were co-transfected with tagged Munc18c
and syntaxin 4, a 30-min insulin exposure decreased the local-
ization of transfected Munc18c to the PM and the association
between Munc18c and syntaxin 4. Interestingly, microinjec-
tion of Munc18c peptide fragments, which compete with en-
dogenous Munc18c for binding to syntaxin 4, resulted in in-
sulin-stimulated GLUT4 vesicle clustering at but not fused
with the plasma membrane [23]. In vivo, Munc18c overexpres-
sion causes skeletal muscle and adipose tissue insulin resis-
tance as a result of ablated insulin-stimulated GLUT4 trans-
location to the cell surface [42]. Taking these data into
account, Munc18c apparently plays a positive fusogenic role
in insulin-stimulated GLUT4 translocation.
In a very recent model presented by Nelson et al. [32], glu-
cosamine-induced insulin resistance is associated with the dis-
ruption of insulin-regulated Munc18c tra⁄cking. In that
work, a subcellular fractionation method that further sepa-
rates each fraction into Triton X-100-soluble and -insoluble
components permitted the detection of Munc18c transloca-
tion. With this approach we also observed that insulin in-
creases the plasma membrane content of Munc18c. As dis-
cussed by Nelson et al. [32] the docking of GLUT4 vesicles
may promote the association of Munc18c with the plasma
membrane, possibly facilitating fusion. Alternatively, acute
insulin stimulation may cause post-translational modi¢ca-
tion(s) of Munc18c. Although there are no data relevant to
Munc18c, Munc18a function can be regulated by protein ki-
nase C and by cyclin-dependent kinase 5-mediated phosphor-
ylation [43,44]. Insulin-regulated tra⁄cking of Munc18c may
represent a link between the proximal insulin signaling cas-
cade and GLUT4 vesicle docking and fusion. In this regard,
O-linked glycosylation is a process that enzymatically attaches
single GlcNAc moieties to serine and threonine residues of
cytosolic and nuclear proteins [45,46], and Munc18c is a cy-
tosolic protein that is found associated with syntaxin 4 at the
plasma membrane [21].
The present work suggests that increases in hexosamine
biosynthesis, su⁄cient to induce insulin resistance, occur si-
multaneously with O-linked glycosylation of Munc18c. One
mechanism by which O-linked glycosylation of Munc18c
could block insulin-stimulated VAMP2^syntaxin 4 interaction
may involve physical blockage of syntaxin 4^Munc18c inter-
action. Alternatively, the putative ability of insulin to regulate
the fusogenic properties of Munc18c may be perturbed by
potential interplay between O-linked glycosylation and phos-
phorylation. Future work will be necessary to determine
whether these or other mechanisms are involved in impaired
GLUT4 vesicle fusion in the glucosamine-induced insulin-re-
sistant state.
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